Stability of revex, nalmefene hydrochloride injection, in injectable solutions

Journal of Pharmaceutical and Biomedical Analysis

Volumn 15, Issue 2, 1996, Pages 221-226

  Murthy, Satya S ^a   Brittain, Harry G ^a  

^a Ohmeda Inc   (United States)

Author keywords

high performance liquid chromatography; injection solutions; nalmefene hydrochloride; Revex

Indexed keywords

NALMEFENE;

ARTICLE; DRUG DETERMINATION; DRUG MIXTURE; DRUG STABILITY; PRIORITY JOURNAL;

EID: 0030296861     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0731-7085(96)01847-X     Document Type: Article

References (8)

1. [1] A. Michael, G. Bolger and B.A. Weissman, Methods Find. Exp. Clin. Pharmacol., 7 (1985) 175-177.
2. [2] D.A. Van Vugt, M.Y. Webb and R.L. Reid, Neuroendocrinology, 49 (1989) 275-280.
3. [3] D.H. Dyson, T. Doherty, G.I. Anderson and W.N. McDonnell, Vet. Surg., 19 (1990) 398-403.
4. [4] P.S.A. Glass, R.M. Jhaveri and R. Smith, Anesth. Analg., 78 (1994) 536-541.
5. [5] K.M. Konieczko, J.G. Jones, M.P. Barrowcliffe, C. Jordan and D.G. Altman, Br. J. Anaesth., 61 (1988) 318-323.
6. [6] W.G. Barsan, D. Seger, D.F. Danzl, L.J. Ling, R. Bartlett, R. Buncher and C. Bryan, Am. J. Emerg. Med., 7 (1989) 155-161.
7. [7] H.G. Brittain, L. Lafferty, P. Bousserski, G. Diegnan, R. Lessor, C. Small and S. Pejaver, PDA J. Sci. Technol., 50 (1996) 35-39.
8. [8] Acute Intravenous Toxicity Study in Mice, Bisnalmefene Succinate, International Research and Development Corporation, Mattawan, MI, Study 530-035 (1993).